“…Further studies should endeavor to define risk factors for bleeding among surgical patients and to determine whether interventions such as repletion of other coagulation factors, intermittent infusion of APC, or restriction of other anticoagulant therapies may be beneficial. P24 Spanish project on benchmarks related to recombinant human activated protein C use: best clinical practices identification MC Martín 1 , J Ruiz 2 , C León 3 , JA Lorente 4 , A López 5 , A Artigas 6 , F Castillo 7 , JC Ruiz 8 1 Hospital General de Cataluña, General Morato s/n, 08221-Sant Cugat del Vallés, Barcelona, Spain; 2 Hospital Sagrat Cor, 08029 Barcelona, Spain; 3 Hospital de Valme, Sevilla, Spain; 4 Hospital Universitario de Getafe, Madrid, Spain; 5 Hospital Infanta Cristina, Badajoz, Spain; 6 Hospital de Sabadell, CSPT, 08208 Sabadell, Barcelona, Spain; 7 Hospital Duque del Infantado, Sevilla, Spain; 8 Purpose To identify best clinical practices (BCPs) using several benchmarks (BMs) related to rhAPC administration as the starting point.…”